Legal Notice

About us

  1. Publisher identification

The Cure51 website is published by Cure51, a simplified joint stock company (société par actions simplifiée)

Capital: 1 547,67 EUR (fixed)

Registered office: 81 rue des Archives, 75003 Paris, France

Email: contact@cure51.com  

RCS:  922 435 433

Intracommunity VAT no.: FR04922435433

Director of publication: Nicolas WOLIKOW

  1. Host provider

The Site is hosted by: Amazon Web Service (AWS)

Name of host: Amazon Web Service

Company name: Amazon Web Services EMEA SARL

Registered office: 38 Av. John F. Kennedy, 1855 Neudorf-Weimershof, Luxembourg

AWS is certified HDS. The certification is available here.

  1. Privacy Policy

Cure51 is committed to user privacy. The Privacy Policy covers the Cure51's website and the eCRF (electronic Clinical Record File) tool developed for the Rosalind study by Cure51, the Patient Profile Platform (PPP).

UNTIL ALL SURVIVE.

From frontline caregivers and patients to researchers and media voices, we bring diverse perspectives together to advance cancer research. Let’s talk.

UNTIL ALL SURVIVE.

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

©2024 Cure51, All Rights Reserved

©2026 Cure51, All Rights Reserved

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.